多方面的肝素:除了抗凝固疗法之外的多种应用
Razia Sultana1,2, Masamichi Kamihira1
1Department of Chemical Engineering, Faculty of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.
Pharmaceuticals (Basel, Switzerland)
|October 26, 2024
概括
肝素是一种重要的抗凝剂,除了血液稀释之外,还显示出有前途的抗炎,抗病毒和抗瘤作用. 纳米技术增强了它对未来医疗应用的治疗潜力.
科学领域:
- 生物化学和药理学 生物化学和药理学
- 生物材料和纳米技术
背景情况:
- 氨酸是一种天然存在的多糖体,近一个世纪以来,它一直是抗凝剂治疗的基石.
- 它的治疗用途超出了抗凝固作用,有记录的抗炎,抗病毒和抗瘤活性.
研究的目的:
- 为了提供一个全面的氨酸的概况,详细说明其当前的治疗效用.
- 探索肝素的新兴应用,特别是生物工程和纳米技术.
- 讨论推进基于肝素的疗法所面临的挑战和机遇.
主要方法:
- 审查关于肝素的生物特性和治疗用途的现有文献.
- 分析纳米技术的最新进展及其对肝素生物功能的影响.
- 在肝素生物工程领域探索未来的研究方向.
主要成果:
- 氨酸表现出多种生物活性,包括抗凝血,抗炎,抗病毒和抗瘤作用.
- 纳米技术的整合显著提高了肝素的治疗效果和输送.
- 扩大用于治疗血栓性疾病,传染病 (例如COVID-19) 和癌症的潜力.
结论:
- 氨酸除了其既定的抗凝剂作用之外,还具有多方面的治疗潜力.
- 纳米技术的进步为利用和改善肝素的生物功能提供了新的策略.
- 进一步的研究和开发至关重要,以充分实现肝素在改善患者结果方面的潜力.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
478
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
478
Venous Thrombosis IV: Nursing Management
2
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
2
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...


